Mangoceuticals, Inc. (MGRX) stock
MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$0.16−0.00 (-0.19%)
Close on Nov 17, 2026Market cap $3.45MP/E –Yield –
Mangoceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Mangoceuticals's price to sales ratio was 11.4× on Nov 11, 2026, against 33.0× a year earlier. Over the last 3 years it ranged from 5.3× to 48.7×, with a median of 12.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 11.4× | −10.6 |
| 2025 | Dec 31, 2025 | 22.0× | +15.2 |
| 2024 | Dec 31, 2024 | 6.8× | – |
See a number that looks wrong?